About Event

Enhancing Drug Delivery Across the Blood-Brain Barrier to Develop More Clinically Meaningful Therapeutics for Neurodegenerative Diseases

Delivering therapeutics across the BBB has been a major obstacle to successful drug development in neurodegeneration. Delivery across this extremely complex interface requires serious collaboration.

Join 60+ BBB specialists to scrutinize progress of existing approaches to deliver more of your biologic therapeutic across the BBB to develop a clinically defining neurodegenerative treatment.